Esclerose Sistêmica: Artigos de Revisão (Systemic Sclerosis: Reviews)

 

■ Systemic scleroderma – definition, clinical Picture and laboratory diagnosis

Anna Kowalska-Kępczyńska

J Clin Med. 2022 May; 11(9): 2299

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9100749/

 

■ Is there still a role for cyclophosphamide in the treatment of systemic sclerosis?

M C Vonk

J Scleroderma Relat Disord 2021, vol (2):117-112

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8892929/

 

■ Esophageal dysfunction in systemic sclerosis: an update

B Li, J Yan, J Pu et al

Rheumatol Ther 2021, vol 8 (4): 1535-1549

 

■ Old and news therapeutic strategies in systemic sclerosis (review)

C Bobeica, E Niculet, A L Tatu et al

Exp Ther Med 2022, vol 23 (2): 134

https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8756424/

 

■ Management of endotelial dysfunction in systemic sclerosis: current andd developing strategies

Djúlio César Zanin-Silva, Maynara Santana-Gonçalves, Marianna Yumi Kawashima-Vasconcelos, Maria Carolina Oliveira

Front Med (Lausanne) 2021; 8: 788250

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727451/

 

■ Therapeutic options for systemic sclerosis: current and future perspectives in tackling imune-mediated fibrosis

Theodoros-Ioannis Papadimitriou, Arjan van Caam, Peter M. van der Kraan, Rogier M. Thurlings

Biomedicines. 2022 Feb; 10(2): 316

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8869277/

 

■ Pathogenic roles of autoantibodies in systemic slcerosis: current understanding in pathogenisis

Jean-Luc Senécal, Sabrina Hoa, Roger Yang, Martial Koenig

J Scleroderma Relat Disord. 2020 Jun; 5(2): 103–129

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8922609/

 

■ Consideration for a combined index for limited cutaneous systemic sclerosis to support drug development and improve outcomes

A Lescoat, S L Murphy, D Roofeh et al

J Scleroderma Relat Disord 2021, vol 6 (1): 66-77

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8313014/

 

■ Mortality and morbidity in scleroderma renal crisis: a systematic literature review

H Kim, F Lefebvre, S Hoa, M Hudson

J Scleroderma Relat Disord 2021, vol 6 (1): 21-36

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8922629/

 

■ Update on morbidity and mortality in systemic sclerosis – related interstitial lung disease

E R Volkmann, A Fisher

J Scleroderma Relat Disord 2021, vol 6 (1): 11-20

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7943067/

 

■ Cardiovascular imaging for systemic sclerosis monitoring and management

Peter Glynn, Sarah Hale, Tasmeen Hussain, Benjamin H. Freed

Front Cardiovasc Med. 2022; 9: 846213

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9008238/

 

■ Atualização na etiopatogênese da esclerose sistêmica

A F Zimmermann, M M M Pizzichini

Rev Bras Reumat 2013, vol 53 (6)

https://www.scielo.br/j/rbr/a/pDsN5ym4VYndGLYZMc8gjVy/?lang=pt

 

■ Acesso gratuito

■ Um dos Blog de Medicina mais acessado em todo o mundo. Mais de 580 temas médicos já disponíveis online

■ Use o mecanismo de busca – PESQUISAR na home page.

■ Acesse ARQUIVO e encontre os temas incluídos no Blog a cada mês, desde maio 2017

■ Blog Internet Médica – www.internetmedica.com.br

■ Médico Responsável: Dr Paulo Fernando Leite

CRMMG: 7026

Belo Horizonte/MG/Brasil

Email: pfleite1873@gmail.com

Maio 2022